Periotherapia Co., Ltd. is pleased to announce that it has been selected as one of 15 finalists in the Deeptech Frontier Challenge for Startups, held as part of Global Startup EXPO 2026, and will participate in the final pitch competition in Osaka on October 6, 2026.

This international pitch competition features deep-tech startups developing innovative, research-driven technologies with the potential for global growth and real-world impact.

We are developing PT0101, an antibody therapy designed to overcome cancer treatment resistance by targeting the tumor microenvironment. Periotherapia will present in the biotech and healthcare category under the title:

Overcome treatment resistance cancer ～A new therapeutic paradigm beyond killing tumor cells～

Kensei Sakata, Head of Clinical Development, will deliver the pitch on behalf of Periotherapia.

Through this opportunity, we look forward to sharing the potential of PT0101 globally and building new relationships that support our international clinical development, fundraising, and strategic partnerships.

We sincerely thank everyone who continues to support us.

Event Details

– Event: Deeptech Frontier Challenge for Startups

– Date and Time: October 6, 2026 (Tuesday), 13:10–14:20 JST, Pitch Session 1

– Venue: Knowledge Theater, 4F, Grand Front Osaka North Building

 　　　 (3-1 Ofuka-cho, Kita-ku, Osaka, Japan)

– Official Website: https://global-startup-expo.com/pitch/